Study Evaluating the Gastrointestinal Safety of PLA-695 Compared to Placebo and Naproxen
Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to provide an initial assessment of the gastrointestinal safety
of a 7-day regimen of PLA-695 compared to placebo or naproxen.